PUBLISHER: The Business Research Company | PRODUCT CODE: 1946627
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946627
Novel spectrometry refers to advanced or innovative spectrometry technologies that improve the analysis of how light interacts with matter, enhancing accuracy and capability in measuring substance properties.
The main spectrometer types in novel spectrometry include atomic absorption spectrometers, mass spectrometers, near-infrared spectrometers, nuclear magnetic resonance spectrometers, Raman spectrometers, and X-ray fluorescence spectrometers. Atomic absorption spectrometers are analytical instruments used to determine elemental concentrations by measuring the absorption of light by vaporized samples. These spectrometers are suitable for organizations of all sizes, including small, mid-sized, and large enterprises, and serve end users in agriculture and pesticide testing, environmental analysis, food biotechnology, forensic analysis, pharmaceutical testing, and others.
Tariffs have influenced the novel spectrometry market by increasing costs for imported precision components, sensors, and advanced optical systems, impacting manufacturing timelines and pricing strategies. High-end spectrometers such as mass spectrometers, NMR spectrometers, and X-ray fluorescence systems are most affected, particularly in regions dependent on cross-border trade like Asia-Pacific and Europe. Small and mid-sized manufacturers face margin pressure, while large players absorb costs through localized sourcing. On the positive side, tariffs are encouraging domestic manufacturing, regional supply chain diversification, and innovation in cost-efficient spectrometry solutions.
The novel spectrometry market research report is one of a series of new reports from The Business Research Company that provides novel spectrometry market statistics, including novel spectrometry industry global market size, regional shares, competitors with a novel spectrometry market share, detailed novel spectrometry market segments, market trends and opportunities, and any further data you may need to thrive in the novel spectrometry industry. This novel spectrometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The novel spectrometry market size has grown strongly in recent years. It will grow from $4.76 billion in 2025 to $5.15 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to pharmaceutical quality control expansion, growth in environmental monitoring regulations, adoption of mass spectrometry in forensic science, rising food safety testing requirements, academic and research laboratory investments.
The novel spectrometry market size is expected to see strong growth in the next few years. It will grow to $6.97 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to automation of analytical laboratories, demand for portable spectrometry devices, growth of personalized medicine research, expansion of industrial process analytics, increased funding for advanced material science. Major trends in the forecast period include AI-enhanced spectral data interpretation, smart factory integration of spectrometry systems, connected and remote spectrometry platforms, cloud-based spectral data management, precision medicine-driven analytical spectrometry.
The increasing demand for personalized medicine is increasingly supporting the expansion of the novel spectrometry market going forward. Personalized medicine is a healthcare approach that customizes treatments based on individual genetic, environmental, and lifestyle factors. Demand for personalized medicine is rising due to advances in genomics, which enable more precise therapies and improved patient outcomes through targeted interventions. Novel spectrometry supports personalized medicine by enabling accurate biomarker analysis and the development of tailored treatment plans, enhancing therapeutic effectiveness. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the US Food and Drug Administration approved 16 new personalized treatments for rare diseases in 2023, compared to six approvals in 2022. Consequently, rising demand for personalized medicine is strengthening the novel spectrometry market.
Leading companies operating in the novel spectrometry market are developing technologically advanced solutions such as next-generation triple-quadrupole mass spectrometers to enhance sensitivity, accuracy, and analytical performance. Advanced triple-quadrupole mass spectrometers are optimized for both quantitative and qualitative analysis of complex samples. For example, in June 2023, Bruker Corporation, a US-based scientific instrument manufacturer, introduced the EVOQ DART-TQ+, a triple-quadrupole mass spectrometer designed for chromatography-free analysis. The system integrates direct analysis in real time ionization, enabling rapid and cost-effective workflows for food, forensic, industrial, and environmental applications.
In June 2023, Thermo Fisher Scientific, a US-based life science and clinical research company, acquired MarqMetrix, Inc. for an undisclosed amount. Through this acquisition, Thermo Fisher Scientific aimed to strategically strengthen its Raman spectroscopy portfolio by incorporating MarqMetrix's complementary and innovative in-line Process Analytical Technology solutions. MarqMetrix is a US-based company providing advanced process Raman spectrometry technologies.
Major companies operating in the novel spectrometry market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Teledyne Photon Instruments, PerkinElmer Inc., LECO Corporation, Endress+Hauser Group, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Horiba Ltd., FLIR Systems Inc., Sciex, JEOL Ltd., Oxford Instruments plc, Rigaku Corporation, Peak Scientific Instruments Ltd., Nanalysis Corp., Scion Instruments, Hiden Analytical Ltd., Labman Automation Ltd., Advion Inc., Exciton Inc., SRI Instruments
North America was the largest region in the novel spectrometry market in 2025. The regions covered in the novel spectrometry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the novel spectrometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The novel spectrometry market includes revenues earned by entities by providing services such as environmental monitoring, trace analysis, high-resolution analysis, and biological and medical diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The novel spectrometry market also consists of sales of portable spectrometers, advanced spectrometers, multimodal spectroscopy systems, and enhanced data processing software. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Novel spectrometry Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses novel spectrometry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for novel spectrometry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The novel spectrometry market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.